Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy
详细信息    查看全文
  • 作者：Haruru Kotani ; Akiyo Yoshimura ; Yayoi Adachi ; Junko Ishiguro…
  • 关键词：Breast cancer ; Stereotactic vacuum assisted biopsy ; Ductal carcinoma in situ ; Sentinel lymph node biopsy
  • 刊名：Breast Cancer
  • 出版年：2016
  • 出版时间：March 2016
  • 年：2016
  • 卷：23
  • 期：2
  • 页码：190-194
  • 全文大小：602 KB
  • 参考文献：1.Bagnall MJ, Evans AJ, Wilson AR, Pinder SE, Denley H, Geraghty JG, et al. Predicting invasion in mammographically detected microcalcification. Clin Radiol. 2001;56:828–32.CrossRef PubMed
    2.Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med. 2004;350:1430–41.CrossRef PubMed
    3.Penco S, Rizzo S, Bozzini AC, Latronico A, Menna S, Cassano E, et al. Stereotactic vacuum-assisted breast biopsy is not a therapeutic procedure even when all mammographically found calcifications are removed: analysis of 4,086 procedures. AJR Am J Roentgenol. 2010;195:1255–60.CrossRef PubMed
    4.Venkataraman S, Dialani V, Gilmore HL, Mehta TS. Stereotactic core biopsy: comparison of 11 gauge with 8 gauge vacuum assisted breast biopsy. Eur J Radiol. 2012;81:2613–9.CrossRef PubMed
    5.Iwase T, Takahashi K, Gomi N, Horii R, Akiyama F. Present state of and problems with core needle biopsy for non-palpable breast lesions. Breast Cancer. 2006;13:32–7.CrossRef PubMed
    6.Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg. 2005;62:253–7.CrossRef PubMed
    7.Ciatto S, Houssami N, Ambrogetti D, Bianchi S, Bonardi R, Brancato B, et al. Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat. 2007;101:291–7.CrossRef PubMed
    8.Crowe JP Jr, Rim A, Patrick RJ, Rybicki LA, Grundfest-Broniatowski SF, Kim JA, et al. Does core needle breast biopsy accurately reflect breast pathology? Surgery. 2003;134:523–6 (discussion 526–528).CrossRef PubMed
    9.Houssami N, Ciatto S, Ellis I, Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer. 2007;109:487–95.CrossRef PubMed
    10.Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–20.CrossRef PubMed
    11.National Comprehensive Cancer Network. Breast cancer v1. [http://​www.​nccn.​org/​professionals/​physician_​gls/​f_​guidelines.​asp#site ].
    12.Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases. Breast Cancer Res Treat. 2006;98:311–4.CrossRef PubMed
    13.Dillon MF, McDermott EW, Quinn CM, O’Doherty A, O’Higgins N, Hill AD. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. J Surg Oncol. 2006;93:559–63.CrossRef PubMed
    14.Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005;200:516–26.CrossRef PubMed
    15.Diepstraten SC, van de Ven SM, Pijnappel RM, Peeters PH, van den Bosch MA, Verkooijen HM, et al. Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy. PLoS One. 2013;8:e77826.CrossRef PubMed PubMedCentral
    16.Sener SF, Winchester DJ, Martz CH, Feldman JL, Cavanaugh JA, Winchester DP, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748–52.CrossRef PubMed
    17.Ronka R, von Smitten K, Tasmuth T, Leidenius M. One-year morbidity after sentinel node biopsy and breast surgery. Breast. 2005;14:28–36.CrossRef PubMed
    18.Haid A, Kuehn T, Konstantiniuk P, Koberle-Wuhrer R, Knauer M, Kreienberg R, et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol. 2002;28:705–10.CrossRef PubMed
    19.van Deurzen CH, Hobbelink MG, van Hillegersberg R, van Diest PJ. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. Eur J Cancer. 2007;43:993–1001.CrossRef PubMed
    20.Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001;182:393–8.CrossRef PubMed
    21.Kuerer HM, Wayne JD, Ross MI. Anaphylaxis during breast cancer lymphatic mapping. Surgery. 2001;129:119–20.CrossRef PubMed
    22.van la Parra RF, Ernst MF, Barneveld PC, Broekman JM, Rutten MJ, Bosscha K. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. Eur J Surg Oncol. 2008;34:631–5.CrossRef
    23.Doyle B, Al-Mudhaffer M, Kennedy MM, O’Doherty A, Flanagan F, McDermott EW, et al. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified? J Clin Pathol. 2009;62:534–8.CrossRef PubMed
    24.Son BK, Bong JG, Park SH, Jeong YJ. Ductal carcinoma in situ and sentinel lymph node biopsy. J Breast Cancer. 2011;14:301–7.CrossRef PubMed PubMedCentral
    25.Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4–16.CrossRef PubMed
    26.Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881–8.CrossRef PubMed
    27.Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7:983–90.CrossRef PubMed
  • 作者单位：Haruru Kotani (1)
    Akiyo Yoshimura (1)
    Yayoi Adachi (1)
    Junko Ishiguro (1)
    Tomoka Hisada (1)
    Mari Ichikawa (1)
    Naomi Gondou (1)
    Masaya Hattori (1)
    Naoto Kondou (1)
    Masataka Sawaki (1)
    Takashi Fujita (1)
    Hiroji Iwata (1)

    1. Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan
  • 刊物主题：Surgical Oncology; Oncology; Surgery; Cancer Research;
  • 出版者：Springer Japan
  • ISSN：1880-4233
文摘
Background This study evaluated the role and need of a sentinel lymph node biopsy (SLNB) in patients with an initial diagnosis of ductal carcinoma in situ (DCIS) made by stereotactic vacuum-assisted biopsy (VAB).
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.